Plain-English translation of NCT06312956 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether ventilotherapy—a breathing device used to treat obstructive sleep apnea—can improve not just your sleep, but also your memory, thinking skills, and emotional wellbeing. Researchers will evaluate your cognitive performance, measure certain proteins in your blood linked to brain health, and assess how you're feeling before and after three weeks of using the treatment.
Sleep apnea can harm your brain's oxygen supply and affect your thinking, mood, and quality of life—but most doctors focus only on treating the breathing problem itself. This study exists to understand whether this treatment can help improve the bigger picture of your health, which may help doctors provide better, more complete care and encourage patients to stick with the therapy.
You likely qualify if…
You likely don't qualify if…
You will use a breathing therapy device for three weeks as part of your regular sleep apnea treatment. Before and after this period, you'll complete thinking and memory tests, answer questionnaires about your mood and wellbeing, and have blood samples taken to check for markers related to brain health. The whole study involves assessment visits before and after the three-week therapy period.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Italy